Abstract
ABSTRACTA noninterventional study under real-life conditions comparing patients receiving prolonged-release oral oxycodone/naloxone with those receiving other World Health Organization (WHO) Step III opioids found patients in the oxycodone/naloxone group had greater quality of life and less low back pain after 12 months. Oxycodone/naloxone was also found to be more cost-effective in the study.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
